Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial-Reference-Cited by-同舟云学术

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

Published:2018-11-14 Issue:7 Volume:219 Page:1026-1034
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Finberg Robert W¹,Lanno Riin²,Anderson David³,Fleischhackl Roman⁴,van Duijnhoven Wilbert⁵,Kauffman Robert S⁶,Kosoglou Teddy³,Vingerhoets Johan⁷,Leopold Lorant³

Affiliation:

1. University of Massachusetts Medical School, Worcester

2. Merelahe Family Doctors Center, Tallinn, Estonia

3. Janssen Research and Development, Titusville, New Jersey

4. Janssen-Cilag, Vienna, Austria

5. Statistics and Decision Sciences, Quantitative Sciences

6. Vertex Pharmaceuticals, Boston, Massachusetts

7. Clinical Virology, Janssen Pharmaceutica, Beerse, Belgium

Funder

Janssen Research and Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/219/7/1026/28079931/jiy547.pdf

Reference13 articles.

1. Randomized study of ondansetron versus domperidone in the treatment of children with acute gastroenteritis;Rerksuppaphol;J Clin Med Res,2013

2. Antivirals–current trends in fighting influenza;Król;Acta Biochim Pol,2014

3. Mortality and morbidity burden associated with A/H1N1pdm influenza virus: who is likely to be infected, experience clinical symptoms, or die from the H1N1pdm 2009 pandemic virus;Miller;PLoS Curr,2009

4. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP);Fiore;MMWR Recomm Rep,2011

5. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses;Fu;Antiviral Res,2016

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08

2. Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial;The Lancet Infectious Diseases;2024-05

3. Passive immunotherapies for the next influenza pandemic;Reviews in Medical Virology;2024-04-18

4. Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitations;European Journal of Medicinal Chemistry;2024-03

5. Efficacy of Pharmacotherapy for Seasonal Influenza in Young and Middle-aged Adults: A Systematic Review and Network Meta-analysis;Internal Medicine;2024